Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Litchfield

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
European Urology|June 25, 2018
Large-scale Analysis Demonstrates Familial Testicular Cancer to have Polygenic AetiologyChey Loveday, Philip Law, Kevin Litchfield, et al.
Bioinformatics (Oxford, England)|July 14, 2020
PhISCS-BnB: a fast branch and bound algorithm for the perfect tumor phylogeny reconstruction problemErfan Sadeqi Azer, Farid Rashidi Mehrabadi, Salem Malikić, et al.
The Lancet. Oncology|July 12, 2017
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysisSamra Turajlic, Kevin Litchfield, Hang Xu, et al.
Human Molecular Genetics|October 5, 2014
Multi-stage genome-wide association study identifies new susceptibility locus for testicular germ cell tumour on chromosome 3q25Kevin Litchfield, Razvan Sultana, Anthony Renwick, et al.
Nature Machine Intelligence|May 28, 2026
Immunotherapy drug target identification using machine learning and patient-derived tumour explant validationMarcellus Augustine, Nuno Rocha Nene, Hongchang Fu, et al.
Nature|December 2, 2016
Genomic evolution and chemoresistance in germ-cell tumoursAmaro Taylor-Weiner, Travis Zack, Elizabeth O'Donnell, et al.
Nature Communications|August 1, 2020
Escape from nonsense-mediated decay associates with anti-tumor immunogenicityKevin Litchfield, James L Reading, Emilia L Lim, et al.
Nature Genetics|October 2, 2024
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolutionClare Puttick, Thomas P Jones, Michelle M Leung, et al.
Cancer Immunology Research|March 24, 2023
The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I-Associated PeptidesGeorges Bedran, Hans-Christof Gasser, Kenneth Weke, et al.
Nature Communications|May 6, 2020
Genomic landscape of platinum resistant and sensitive testicular cancersChey Loveday, Kevin Litchfield, Paula Z Proszek, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
European Urology|June 25, 2018
Large-scale Analysis Demonstrates Familial Testicular Cancer to have Polygenic AetiologyChey Loveday, Philip Law, Kevin Litchfield, et al.
Bioinformatics (Oxford, England)|July 14, 2020
PhISCS-BnB: a fast branch and bound algorithm for the perfect tumor phylogeny reconstruction problemErfan Sadeqi Azer, Farid Rashidi Mehrabadi, Salem Malikić, et al.
The Lancet. Oncology|July 12, 2017
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysisSamra Turajlic, Kevin Litchfield, Hang Xu, et al.
Human Molecular Genetics|October 5, 2014
Multi-stage genome-wide association study identifies new susceptibility locus for testicular germ cell tumour on chromosome 3q25Kevin Litchfield, Razvan Sultana, Anthony Renwick, et al.
Nature Machine Intelligence|May 28, 2026
Immunotherapy drug target identification using machine learning and patient-derived tumour explant validationMarcellus Augustine, Nuno Rocha Nene, Hongchang Fu, et al.
Nature|December 2, 2016
Genomic evolution and chemoresistance in germ-cell tumoursAmaro Taylor-Weiner, Travis Zack, Elizabeth O'Donnell, et al.
Nature Communications|August 1, 2020
Escape from nonsense-mediated decay associates with anti-tumor immunogenicityKevin Litchfield, James L Reading, Emilia L Lim, et al.
Nature Genetics|October 2, 2024
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolutionClare Puttick, Thomas P Jones, Michelle M Leung, et al.
Cancer Immunology Research|March 24, 2023
The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I-Associated PeptidesGeorges Bedran, Hans-Christof Gasser, Kenneth Weke, et al.
Nature Communications|May 6, 2020
Genomic landscape of platinum resistant and sensitive testicular cancersChey Loveday, Kevin Litchfield, Paula Z Proszek, et al.
Pageof 10